<!DOCTYPE html>

<!--
  Created : 12/2/2011 7:26:42 AM
  Author : Tom Coleman
  Copyright : 2011-2011
  By : University of Missippi Medical Center
-->

<html>
<head>
<title> Model </title>
<link rel='stylesheet' type='text/css' href='../Style.CSS'>
</head>

<body>

<img src='../SmallTitle.PNG'>
<img src='SmallModel.PNG'>
<a href='Docs_Aldosterone.html'><img src='../Back.PNG'></a>
<p>
QHP 2008 / Aldosterone.DOCS<br>
Created : 27-Mar-09<br>
Last Modified : 27-Mar-09<br>
Author : Tom Coleman<br>
Copyright : 2009<br>
<br>
&lt;structurename&gt; AldoTumor &lt;/structurename&gt;<br>
<br>
&lt;vardoc&gt;<br>
&lt;name&gt; AldoTumor.SecretionRate &lt;/name&gt;<br>
&lt;topic&gt; AldoTumor - Overview &lt;/topic&gt;<br>
&lt;/vardoc&gt;<br>
<br>
<br>
&lt;topicdoc&gt;<br>
&lt;name&gt; AldoTumor - Overview &lt;/name&gt;<br>
&lt;label&gt; Overview &lt;/label&gt;<br>
&lt;content&gt;<br>
<br>
Primary aldosteronism or "Conn's syndrome" occurs when a <br>
small tumor of the zona glomerulosa cells develops and <br>
secretes large amounts of aldosterone. The most important <br>
effects are hypokalemia, a slight increase in extracellular <br>
fluid volume and blood volume, a very slight increase in <br>
plasma sodium concentration and hypertension. <br>
<br>
Patients with primary aldosteronism often exhibit occasional <br>
periods of muscle paralysis caused by hypokalemia. The <br>
paralysis is caused by a depressant effect of low extracellular<br>
potassium concentration on action potential transmission by <br>
nerve fibers.<br>
<br>
The model user can set secretion rates of an aldosterone <br>
secreting tumor. Normal secretion rate of aldosterone <br>
is 330.0 pMol/Min<br>
<br>
JW Conn. Primary aldosteronism, a new clinical syndrome. <br>
J Lab Clin Invest 45:3 - 17, 1955.<br>
<br>
NM Kaplan. Primary aldosteronism with malignant hypertension.<br>
New England Journal of Medicine 269:1282 - 1286, 1963.<br>
<br>
RC Tarazi, MM ibrahim, EL Bravo, HP Dustan. Hemodynamic<br>
characteristics of primary aldosteronism.<br>
New England Journal of Medicine 289: 1330 -1335, 1973.<br>
<br>
 <br>
&lt;/content&gt;<br>
&lt;/topicdoc&gt;<br>
<br>
<br>
<br>
End

<p><img src='../Footer.PNG'>

</body>
</html>
